Coral Gables, FLORIDA14 Active Studies

Interstitial Cystitis Clinical Trials in Coral Gables, FLORIDA

Find 14 actively recruiting interstitial cystitis clinical trials in Coral Gables, FLORIDA. Connect with local research sites and explore new treatment options.

14
Active Trials
12
Sponsors
3,824
Enrolling

Recruiting Interstitial Cystitis Studies in Coral Gables

RecruitingCoral Gables, FLORIDANCT06855160

A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age

This study aims to assess the immune response and safety of GSK's candidate chickenpox and marketed MMR vaccines when given to children 12 to 15 months of age via a muscle injection. It compares the G...

900 participants
GlaxoSmithKline
View Study Details
RecruitingCoral Gables, FLORIDANCT06461897

A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

Atopic dermatitis (AD) is a skin condition that may cause a rash and itching due to inflammation of the skin. Topical therapies applied over the skin may not be enough to control the AD in trial parti...

675 participants
AbbVie
View Study Details
RecruitingCoral Gables, FLORIDANCT06395948

A Study Evaluating APG777 in Atopic Dermatitis

This is a two-part study that will evaluate the safety and efficacy of APG777 in participants with moderate-to-severe Atopic Dermatitis (AD). Part A (Proof-of-concept) and Part B (Dose-regimen Finding...

431 participants
Apogee Therapeutics, Inc.
View Study Details
RecruitingCoral Gables, FLORIDANCT05672576

A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus

The goal of this clinical trial is to see how well cenerimod reduces symptoms of Systemic Lupus Erythematous in adult patients with moderate to severe symptoms. The main questions it aims to answer ar...

420 participants
Viatris Innovation GmbH
View Study Details
RecruitingCoral Gables, FLORIDANCT07003425

A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

This is a multicenter, double-blind, Long-Term Extension (LTE) study to evaluate the long-term safety and efficacy of APG777 in patients with moderate-to-severe AD who have completed treatment in an A...

350 participants
Apogee Therapeutics, Inc.
View Study Details
RecruitingCoral Gables, FLORIDANCT06902558

A Study to Assess Adverse Events and Effectiveness of IntraVenous Infusions of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common genetic cause of kidney disease that causes fluid-filled cysts to develop in the kidneys. The purpose of this study is to assess...

240 participants
AbbVie
View Study Details
RecruitingCoral Gables, FLORIDANCT06790121

A Study to Investigate the Efficacy and Safety of Subcutaneous Lunsekimig (SAR443765) Compared With Placebo in Adult Participants With Moderate-to-severe Atopic Dermatitis

This is a parallel, Phase 2b, randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy, safety, and tolerability of lunsekimig monotherapy in adult participants (aged 18 ...

144 participants
Sanofi
View Study Details
RecruitingCoral Gables, FLORIDANCT03997786

A Study of Tildrakizumab in Pediatric Subjects With Chronic Plaque Psoriasis

The study has been designed with three components. Part A is an open label PK study followed by a randomized trial component (Part B) followed by open label Long Term Extension (LTE). The initial PK ...

130 participants
Sun Pharmaceutical Industries Limited
View Study Details
RecruitingCoral Gables, FLORIDANCT07150845

Phase 2b Study of EVO756 in Adults With Atopic Dermatitis

This study will evaluate the efficacy and safety of different doses of EVO756 in adults with moderate to severe atopic dermatitis....

120 participants
Evommune, Inc.
View Study Details
RecruitingCoral Gables, FLORIDANCT05677451

24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up

The purpose of this trial is: 1. to assess the efficacy, pharmacokinetics, and safety of remibrutinib vs. placebo in adolescents from 12 to \< 18 years of age suffering from chronic spontaneous urtic...

100 participants
Novartis Pharmaceuticals
View Study Details
RecruitingCoral Gables, FLORIDANCT06998056

Safety Study of Roflumilast Cream 0.05% in Infants Aged 3 Months to Less Than 2 Years With Atopic Dermatitis

This study will assess the safety and tolerability of ARQ-151 cream 0.05% applied once a day for 4 weeks in infants with atopic dermatitis (eczema)....

100 participants
Arcutis Biotherapeutics, Inc.
View Study Details
RecruitingCoral Gables, FLORIDANCT07011706

ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis

This study evaluates ATI-045 versus placebo in patients with Moderate-to-Severe Atopic Dermatitis....

96 participants
Aclaris Therapeutics, Inc.
View Study Details
RecruitingCoral Gables, FLORIDANCT06108024

A Trial to Evaluate the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratosis

The objective of the trial is to evaluate the safety and efficacy of SM-020 gel 1.0% in subjects with Seborrheic Keratosis (SK) compared to vehicle gel. It is a randomized, double-blind, vehicle-contr...

60 participants
DermBiont, Inc.
View Study Details
RecruitingCoral Gables, FLORIDANCT04557956

Testing the Addition of the Anti-cancer Drug, Tazemetostat, to the Usual Treatment (Dabrafenib and Trametinib) for Metastatic Melanoma That Has Progressed on the Usual Treatment

This phase I/II trial investigates the best dose, possible benefits and/or side effects of tazemetostat in combination with dabrafenib and trametinib in treating patients with melanoma that has a spec...

58 participants
National Cancer Institute (NCI)
View Study Details

About Interstitial Cystitis Clinical Trials in Coral Gables

Interstitial cystitis/bladder pain syndrome is a chronic condition causing bladder pressure, bladder pain, and sometimes pelvic pain. It primarily affects women and can significantly impact quality of life. Treatment includes dietary changes, bladder instillations, oral medications, and neuromodulation.

There are currently 14 interstitial cystitis clinical trials recruiting participants in Coral Gables, FLORIDA. These studies are seeking a combined 3,824 participants. Research is being sponsored by GlaxoSmithKline, AbbVie, Apogee Therapeutics, Inc. and 9 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Interstitial Cystitis Clinical Trials in Coral Gables — FAQ

Are there interstitial cystitis clinical trials in Coral Gables?

Yes, there are 14 interstitial cystitis clinical trials currently recruiting in Coral Gables, FLORIDA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Coral Gables?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Coral Gables research site will contact you about next steps.

Are clinical trials in Coral Gables free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Coral Gables studies also compensate for your time and travel.

What interstitial cystitis treatments are being tested?

The 14 active trials in Coral Gables are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial cystitis.

Data updated March 2, 2026 from ClinicalTrials.gov